Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
J. Andrew Livingston, Kenneth R. Hess, Aung Naing, David S. Hong, Shreyaskumar Patel, Robert S. Benjamin, Joseph A. Ludwig, Anthony Conley, Cynthia E. Herzog, Pete Anderson, Funda Meric-Bernstam, Razelle Kurzrock, Vivek Subbiah
Published Jul 28, 2016 · Vol. 7, No. 39 · pp. 64421-64430
Marta Usó, Eloisa Jantus-Lewintre, Roy M. Bremnes, Silvia Calabuig, Ana Blasco, Enrique Pastor, Irene Borreda, Sonia Molina-Pinelo, Luis Paz-Ares, Ricardo Guijarro, Miguel Martorell, Jerónimo Forteza, Carlos Camps, Rafael Sirera
Published Jul 24, 2016 · Vol. 7, No. 33 · pp. 52849-52861
Eric W. Prince, Ilango Balakrishnan, Monil Shah, Jean M. Mulcahy Levy, Andrea M. Griesinger, Irina Alimova, Peter S. Harris, Diane K. Birks, Andrew M. Donson, Nathan Davidson, Marc Remke, Michael D. Taylor, Michael H. Handler, Nicholas K. Foreman, Sujatha Venkataraman, Rajeev Vibhakar
Published Jul 19, 2016 · Vol. 7, No. 33 · pp. 53881-53894
